Ifabotuzumab Biosimilar – Anti-EPHA3, REK4 mAb – Research Grade

Reference:
Size

,

Isotype

IgG1, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameIfabotuzumab Biosimilar - Anti-EPHA3, REK4 mAb - Research Grade
SourceCAS 1234137-51-9
SpeciesHumanized
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsIfabotuzumab,KB-004,EPHA3, REK4,anti-EPHA3, REK4
ReferencePX-TA1398
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Ifabotuzumab Biosimilar - Anti-EPHA3, REK4 mAb - Research Grade

General information on Anti-EPHA3/REK4[Homo sapiens] (Ifabotuzumab) Monoclonal Antibody

Ifabotuzumab has been investigated for the treatment of Myelodysplastic syndrome, Myelofibrosis and Cancer.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Ifabotuzumab Biosimilar – Anti-EPHA3, REK4 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human EPHA3 recombinant protein
Antigen

Human EPHA3 recombinant protein

PX-P6099 500$
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

PTX17885 214$
Ifabotuzumab ELISA Kit
ELISA

Ifabotuzumab ELISA Kit

KPTX218 1547$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products